Table 3. Estimated prevalence of chronic hepatitis C virus among immigrants in Canada, per period of arrival and overall.
| Population | Population size estimate | Arrival before 2016 | Arrival in 2016–2021 | Overall | |||
|---|---|---|---|---|---|---|---|
| Prevalence (%) | Estimated number | Prevalence (%) | Estimated number | Prevalence (%) | Estimated number | ||
| Immigrants from countries with low prevalence (<2%) | 7,082,480 | 0.53% (0.37%–0.91%) |
31,680 (22,000–54,791) |
0.49% (0.36%–0.91%) |
5,352 (3,888–9,795) |
0.52% (0.37%–0.91%) |
37,032 (25,888–64,586) |
| Immigrants from countries with intermediate-to-high prevalence (≥2%) | 1,276,405 | 2.31% (1.64%–3.53%) |
23,838 (16,953–36,438) |
1.76% (1.16%–3.32%) |
4,301 (2,843–8,145) |
2.20% (1.55%–3.49%) |
28,139 (19,796–44,582) |
| All immigrants | 8,358,885 | 0.79% (0.55%–1.30%) |
55,519 (38,953–91,228) |
0.73% (0.51%–1.35%) |
9,653 (6,731–17,940) |
0.78% (0.55%–1.31%) |
65,172 (45,684–109,168) |